Yüklüyor......

The GIST of Targeted Therapy for Malignant Melanoma

The high response rates to the tyrosine kinase inhibitor imatinib in KIT-mutated gastrointestinal stromal tumors (GIST) has led to a paradigm shift in cancer treatment. In a parallel fashion, the field of melanoma is shifting with the utilization of targeted therapy to treat BRAF-mutated melanoma. W...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bello, Danielle M., DeMatteo, Ronald P., Ariyan, Charlotte E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4041068/
https://ncbi.nlm.nih.gov/pubmed/24531699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3373-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!